| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $781.6M | +79.2% |
| Cost of Revenue | $621.3M | +59.3% |
| R&D Expense | $600K | +0.0% |
| SG&A Expense | $70.4M | +28.9% |
| Operating Income | $32.5M | +150.7% |
| Pre-tax Income | -$2.5M | +97.3% |
| Income Tax | $600K | +100.0% |
| Net Income | -$3.1M | +96.7% |
| EPS (Basic) | -$0.27 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.4M | +105.0% |
| Accounts Receivable | $154.3M | +49.5% |
| Inventory | $25.7M | +14.7% |
| Current Assets | $254.7M | +54.6% |
| Total Assets | $465.9M | +20.2% |
| Current Liabilities | $154.4M | +25.8% |
| Long-term Debt | $283.4M | +3.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.7M | +128.2% |
| Capital Expenditures | $35.6M | +223.6% |
| Investing Cash Flow | -$18.7M | -515.6% |
| Financing Cash Flow | $32.4M | +1.3% |
| Free Cash Flow | -$19.9M | +70.1% |
| +97.5% |
| EPS (Diluted) | -$0.27 | +97.5% |
| Stockholders' Equity |
| -$15.8M |
| +69.3% |